Abstract
Approximately 10% of the population with mixed cryoglobulinemia (MC) have no evidence of HCV infection. In these patients, a wide number of infectious agents have been associated with cryoglobulinemia, although only HBV and HIV have a well- documented role in causing the disorder. Several connective tissue (mainly systemic lupus erythematosus, Sjögren’s syndrome, and systemic sclerosis) and lymphoproliferative (in most cases B-cell non-Hodgkin lymphoma) diseases have also been shown to play an etiologic role in some cases of HCV-negative MC. Fewer than 5% of cryoglobulinemic patients show no identifiable underlying diseases and they are therefore considered as having “essential” MC. In HCV-negative MC, an occult HCV infection should also be taken into account. The clinical manifestations, cryoglobulin levels, and survival rates in MC patients with and without HCV seem not to differ significantly, although the data are conflicting. In symptomatic MC, therapy should aim at improvement or resolution of clinical manifestations, as elimination of the causative factor is impossible in most cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569–570
Casato M, TaIiani G, Pucillo LP et al (1991) Cryoglobulinaemia and epatitis C virus. Lancet 337:1047–1048
Ferri C, Greco F, Longombardo G et al (1991) Association between hepatitis C virus and mixed cryoglobulinaemia. Clin Exp Rheumatol 9:621–624
Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490–1495
Misiani R, Bellavita P, Fenili D et al (1992) Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573–577
Lunel F, Musset L, Cacoub P et al (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300
Monti G, Galli M, Invenizzi F et al (1995) Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM 88:115–126
Dammacco F, Sansonno D, Piccoli C et al (2001) The cryoglobulins: an overview. Eur J Clin Invest 31:628–638
Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33:355–374
Saadoun D, Sellam J, Ghillani-Dalbin P et al (2006) Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166:2101–2108
Weiner SM, Berg T, Berthold H et al (1998) A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 29:375–384
Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18:54–63
Gorevic PD, Kassab HJ, Levo Y et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287–308
Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42:2507–2516
Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins. J Clin Pathol 55:4–13
Granel B, Serratrice J, Morange PE et al (2004) Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-Guerin. Clin Exp Rheumatol 22:481–482
Hermida Lazcano I, Saez Méndez L, Solera Santos J (2005) Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis. J Infect 51:e257–e259
Trendelenburg M, Schifferli JA (1998) Cryoglobulins are not essential. Ann Rheum Dis 57:3–5
Galli M, Invernizzi F, Chemotti M et al (1986) Cryoglobulins and infectious diseases. Ric Clin Lab 16:301–313
Galli M (1995) Viruses and cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S63–S70
Iori GP, Buonanno G (1972) Chronic hepatitis and cirrhosis of the liver in cryoglobulinemia. Gut 13:610–613
Florin-Christensen A, Roux MEB, Arana RM (1974) Cryoglobulins in acute and chronic liver diseases. Clin Exp Immunol 16:599–605
Levo Y, Gorevic PD, Kassab HJ et al (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296:1501–1504
Dienstag JL, Wands JR, Isselbacher KJ (1977) Hepatitis B and essential mixed cryoglobulinemia. N Engl J Med 297:946–947
Popp JW Jr, Dienstag JL, Wands JR, Bloch KJ (1980) Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 92:379–383
Galli M (1991) Cryoglobulinaemia and serological markers of hepatitis viruses. Lancet 338:758–759
Galli M, Monti G, Invernizzi F et al (1992) Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicenter study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC). Ann Ital Med Int 7:209–214
Ferri C (2008) Mixed cryoglobulinernia. Orphan J Rare Dis 3:25
Cohen P, Roulot D, Ferrière F et al (1997) Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. Clin Exp Rheumatol 15:523–527
Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM (1999) Mixed cryoglobulinemia in HIV-l infection: the role of HIV-1. Ann Intem Med 130:226–230
Fabris P, Tositti G, Giordani MT et al (2003) Prevalence and clinical significance of circulating cryoglobulins in HIV -positive patients with and without co-infection with hepatitis C virus. J Med Virol 69:339–343
Scotto G, Cibelli DC, Saracino A et al (2006) Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection. J Infect 52:294–299
Kosmas N, Kontos A, Panayiotakopoulos G et al (2006) Decreased prevalence of mixed cryoglobulinemia in the HAART era among HIV -positive, HCV-negative patients. J Med Virol 78:1257–1261
Antinori S, Galimberti L, Rusconi S et al (1995) Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 13(Suppl 13):S157–S159
Palacios R, Santos J, Valdivielso P, Marquez M (2002) Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 11:60–63
Trejo O, Ramos-Casals M, Garcia-Carrasco M et al (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single centre. Medicine (Baltimore) 80:252–262
Mascia MT, Ferrari D, Campioli D et al (2007) Non HCV-related mixed cryoglobulinemia. Dig Liver Dis 39(Suppl l):S61–S64
Rieu V, Cohen P, André MH et al (2002) Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41:290–300
Cacoub P, Fabiani FL, Musset L et al (1994) Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96:124–132
Tarantino A, Campise M, Banfi G et al (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47:618–623
Della Rossa A, Marchi F, Catarsi E et al (2008) Mixed cryoglobulinemia and mortality: a review of the literature. Clin Exp Rheumatol 26(Suppl 51):S105–S108
Castillo I, Pardo M, Bartolomé J et al (2004) Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver function tests is unknown. J Infect Dis 189:7–14
Casato M, Lilli D, Donato G et al (2003) Occult hepatitis C virus infection in type II mixed cryoglobulinaemia. J ViraI Hepat 10:455–459
Ferri C, Moriconi L, Gremignai G et al (1986) Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. Nephron 43:246–253
Ferri C, Pietrogrande M, Cecchetti C et al (1989) Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med 87:519–524
Monti G, Saccardo F, Rinaldi G et al (1995) Colchicine in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S197–S199
Tavoni A, Mosca M, Ferri C et al (1995) Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S191–S195
Zaja F, De Vita S, Mazzaro C et al (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827–3834
Sansonno D, De Re V, Lauletta G, et al (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101:3818–3826
Roccatello D, Baldovino S, Rossi D et al (2004) Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19:3054–3061
Cacoub P, Delluc A, Saadoun D et al (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis 67:283–287
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Galli, M., Sollima, S., Monti, G. (2012). HCV-Negative Mixed Cryoglobulinemia: Facts and Fancies. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_30
Download citation
DOI: https://doi.org/10.1007/978-88-470-1705-4_30
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1704-7
Online ISBN: 978-88-470-1705-4
eBook Packages: MedicineMedicine (R0)